Work

A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer

Year: 2013

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccr.2013.11.001

Authors: Ravi K. Anchoori, Balasubramanyam Karanam, Shiwen Peng, Joshua W. Wang, Rosie Jiang, Toshihiko Tanno, Robert Z. Orlowski, William Matsui, Ming Zhao, Michelle A. Rudek, Chien-fu Hung, Xiang Chen, Kylie J. Walters, Richard B.S. Roden

Institutions: Johns Hopkins University, The University of Texas MD Anderson Cancer Center, University of Minnesota, Frederick National Laboratory for Cancer Research, National Cancer Institute, Center for Cancer Research, Johns Hopkins Medicine

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Johns Hopkins University, Institute for Basic Science, National Institutes of Health, Sidney Kimmel Comprehensive Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, National Cancer Institute, National Center for Research Resources

Awards: G1165598027, G1353051725, Institute for Clinical and Translational Research (UL1), Cellular diversity and clinical relevance of stem cells in pancreatic cancer, G536099884, G592274421, G7942570633, G8499458690, SPORE in Cervical Cancer

OpenAlex ID: W1997012817

FWCI: 4.975

Cites: 40

Cited by: 162

Related to: 10